Systolic Ankle arteriaL Pressure and Transcutaneous oximetrY During a TURTLE Test in Athletes

Iliac Kinking Clinical Trial

— SALTY-TURTLE  

Official title:

Application de l'oxymétrie Dynamique et Des Index de Pression Pour le Diagnostic Des Plicatures Iliaques du Sportif

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03568201
• Other study ID #: 2018 A01046/ 49
• Status: Completed
• Phase: N/A
• Start date: December 17, 2018
• Est. completion date: December 16, 2020

Study information

• Verified date: August 2020
• Source: University Hospital, Angers
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Aim of the study is to test the feasibility of transcutaneous oxygen pressure (TcPO2) recording in the diagnosis of iliac kinking in 20 patients with suspected of endofibrosisoriliackinking and 40 asymptomatic control heathy subjects

Description:

Patients suspected of PES and healthy controls after detailled explanation of the protocol will have a recording of tcpO2 on both calves and will perform a series of thigh flexion in the standing position.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 60
• Est. completion date: December 16, 2020
• Est. primary completion date: December 16, 2020
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Age over 18 years Insurance company affiliation Symptoms consistent with iliac kinking (patients) or absence of symptoms (controls)

Exclusion Criteria:

• Refuse to participate Exclusion period from another protocole Non affiliation to the French healthcare system

Related Conditions & MeSH terms

• Iliac Kinking

Intervention

Diagnostic Test:
• Transcutaneous oximetry
Measurement of TcpO2 on calves and chests. Calculation of the DROP index (decrease from rest of oxygen pressure)on both calves.

Locations

Country	Name	City	State
France	Centre hospitalier universitaire	Angers

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Angers

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Presence of a significant DROP decrease	Comparison of DROP value between PES patients and controls	1 hour